British Columbia Investment Management Corp cut its position in Walgreens Boots Alliance Inc. (NASDAQ:WBA) by 13.7% during the third quarter, according to its most recent 13F filing with the SEC. The fund owned 387,436 shares of the pharmacy operator’s stock after selling 61,471 shares during the period. British Columbia Investment Management Corp’s holdings in Walgreens Boots Alliance were worth $31,235,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Exxonmobil Investment Management Inc. TX boosted its position in Walgreens Boots Alliance by 6.5% in the second quarter. Exxonmobil Investment Management Inc. TX now owns 223,698 shares of the pharmacy operator’s stock worth $18,627,000 after buying an additional 13,579 shares in the last quarter. Thompson Rubinstein Investment Management Inc. OR boosted its position in Walgreens Boots Alliance by 4.0% in the second quarter. Thompson Rubinstein Investment Management Inc. OR now owns 164,632 shares of the pharmacy operator’s stock worth $13,709,000 after buying an additional 6,256 shares in the last quarter. CHICAGO TRUST Co NA boosted its position in Walgreens Boots Alliance by 5.2% in the second quarter. CHICAGO TRUST Co NA now owns 50,009 shares of the pharmacy operator’s stock worth $4,164,000 after buying an additional 2,468 shares in the last quarter. DNB Asset Management AS boosted its position in Walgreens Boots Alliance by 7.6% in the second quarter. DNB Asset Management AS now owns 85,052 shares of the pharmacy operator’s stock worth $7,082,000 after buying an additional 6,000 shares in the last quarter. Finally, Daiwa SB Investments Ltd. boosted its position in Walgreens Boots Alliance by 411.3% in the second quarter. Daiwa SB Investments Ltd. now owns 73,990 shares of the pharmacy operator’s stock worth $6,156,000 after buying an additional 59,520 shares in the last quarter. 60.76% of the stock is currently owned by institutional investors.

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Shares of Walgreens Boots Alliance Inc. (NASDAQ:WBA) traded up 0.45% during trading on Friday, reaching $84.43. The company’s stock had a trading volume of 1,587,742 shares. The company has a market capitalization of $91.46 billion, a PE ratio of 22.10 and a beta of 1.19. Walgreens Boots Alliance Inc. has a 1-year low of $71.50 and a 1-year high of $87.05. The stock has a 50 day moving average of $81.28 and a 200-day moving average of $81.05.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Thursday, October 20th. The pharmacy operator reported $1.07 earnings per share for the quarter, beating the consensus estimate of $0.99 by $0.08. The business had revenue of $28.60 billion for the quarter, compared to the consensus estimate of $29.06 billion. Walgreens Boots Alliance had a return on equity of 16.33% and a net margin of 3.56%. The business’s quarterly revenue was up .4% compared to the same quarter last year. During the same quarter last year, the business posted $0.88 earnings per share. On average, analysts expect that Walgreens Boots Alliance Inc. will post $5.01 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Monday, December 12th. Stockholders of record on Thursday, November 17th will be given a $0.375 dividend. The ex-dividend date is Tuesday, November 15th. This represents a $1.50 annualized dividend and a dividend yield of 1.78%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 39.27%.

WARNING: “Walgreens Boots Alliance Inc. (WBA) Shares Sold by British Columbia Investment Management Corp” was first posted by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are accessing this story on another website, it was copied illegally and republished in violation of U.S. & international trademark & copyright laws. The legal version of this story can be accessed at https://www.thecerbatgem.com/2016/11/27/walgreens-boots-alliance-inc-wba-shares-sold-by-british-columbia-investment-management-corp.html.

WBA has been the topic of a number of research reports. Deutsche Bank AG reaffirmed a “buy” rating and issued a $94.00 price objective on shares of Walgreens Boots Alliance in a research note on Friday, September 9th. Robert W. Baird reaffirmed an “outperform” rating and issued a $95.00 price objective on shares of Walgreens Boots Alliance in a research note on Saturday, September 10th. Barclays PLC set a $79.00 price objective on Walgreens Boots Alliance and gave the stock a “hold” rating in a research note on Friday, October 21st. Jefferies Group set a $95.00 price objective on Walgreens Boots Alliance and gave the stock a “buy” rating in a research note on Sunday, October 23rd. Finally, Leerink Swann reaffirmed an “outperform” rating and issued a $95.00 price objective on shares of Walgreens Boots Alliance in a research note on Monday, September 19th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and thirteen have given a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $90.30.

In other news, EVP Kathleen Wilson-Thompson sold 23,996 shares of the firm’s stock in a transaction that occurred on Thursday, September 8th. The stock was sold at an average price of $85.00, for a total value of $2,039,660.00. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director William C. Foote sold 2,067 shares of the firm’s stock in a transaction that occurred on Wednesday, November 2nd. The shares were sold at an average price of $81.30, for a total value of $168,047.10. Following the completion of the transaction, the director now owns 24,623 shares in the company, valued at approximately $2,001,849.90. The disclosure for this sale can be found here. 21.10% of the stock is owned by insiders.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

5 Day Chart for NASDAQ:WBA

Receive News & Stock Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related stocks with our FREE daily email newsletter.